{"filing":{"accession_number":"0001437749-26-024663","cik":"0000070487","ticker":"NRC","company_name":"NRC HEALTH","form":"8-K","filing_date":"2026-07-28","report_date":"2026-07-28","primary_document":"nrc20260724_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/70487/000143774926024663/nrc20260724_8k.htm"},"events":[{"id":21036,"run_id":18958,"accession_number":"0001437749-26-024663","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"NRC Health issued a press release on July 28, 2026 announcing its second quarter 2026 financial and operating results, including TRCV of $151.9 million (up 11% YoY), revenue of $35.4 million (up 4% YoY), GAAP net loss of ($3.3) million, and Adjusted Net Income of $6.9 million. The press release includes condensed consolidated financial statements and is furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures under Item 2.02.","company_name":"NRC HEALTH","ticker":"NRC","filing_date":"2026-07-28","form":"8-K","submitted_at":null,"items":[{"id":20569,"accession_number":"0001437749-26-024663","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"NRC Health issued a press release on July 28, 2026 announcing its second quarter 2026 financial and operating results, including TRCV of $151.9 million (up 11% YoY), revenue of $35.4 million (up 4% YoY), GAAP net loss of ($3.3) million, and Adjusted Net Income of $6.9 million. The press release includes condensed consolidated financial statements and is furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:04:59.772466+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":20569,"accession_number":"0001437749-26-024663","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"NRC Health issued a press release on July 28, 2026 announcing its second quarter 2026 financial and operating results, including TRCV of $151.9 million (up 11% YoY), revenue of $35.4 million (up 4% YoY), GAAP net loss of ($3.3) million, and Adjusted Net Income of $6.9 million. The press release includes condensed consolidated financial statements and is furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures under Item 2.02.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-28T20:04:59.772466+00:00","company_name":"NRC HEALTH","ticker":"NRC","filing_date":"2026-07-28"}]}